当前位置: 首页 > 期刊 > 《医学信息》 > 20205
编号:13507819
18F-脱氧葡萄糖PET/CT代谢参数对食管恶性肿瘤患者放化疗疗效的预测价值(5)
http://www.100md.com 2020年2月5日 《医学信息》 20205
     [11]Park JK,Kim JJ,Moon SW.A study about different findings of PET-CT between neoadjuvant and non-neoadjuvant therapy:SUVmax is not a reliable predictor of lymphatic involvement after neoadjuvant therapy for esophageal cancer[J].J Thorac Dis,2016,8(5):784-794.

    [12]李建成,孙伟杰,陈少兴,等.18F-FDG PET-CT代谢参数对食管癌近期疗效预测价值研究[J].中华肿瘤防治杂志,2017,24(16):1157-1161.

    [13]Sasaki K,Uchikado Y,Okumura H,et al.Role of 18F-FDG-PET/CT in Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemoradiotherapy[J].Anticancer Res,2017,37(2):859-864.

    [14]Huang JW,Yeh HL,Hsu CP,et al.To evaluate the treatment response of locally advanced esophageal cancer after preoperative chemoradiotherapy by FDG-PET/CT scan[J].J Chin Med Assoc,2015,78(4):229-234.

    [15]Nakajo M,Jinguji M,Nakabeppu Y,et al.Texture analysis of 18F-FDG PET/CT to predict tumour response and prognosis of patients with esophageal cancer treated by chemoradiotherapy[J].Eur J Nucl Med Mol Imaging,2017,44(2):206-214.

    收稿日期:2019-12-12;修回日期:2020-01-07

    編辑/杜帆, http://www.100md.com(居热提·阿扎提 柴黎明 娜仁花)
上一页1 2 3 4 5